Organogenesis Holdings Inc. is a US-based company that develops and manufactures solutions for the advanced wound care, and surgical and sports medicine markets. Their products include advanced wound care products such as Affinity, Apligraf, and Dermagraft, as well as surgical and sports medicine products like NuCel, ReNu, FiberOS, and OCMP that are primarily used in orthopedic and neurosurgical applications. They distribute their products through direct sales force and independent agencies to hospitals, wound care centers, government facilities, ambulatory service centers, and physician offices.